Cardiff Oncology, Inc. (CRDF) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Cardiff Oncology, Inc. (CRDF) closed at USD 0.97 on 2026-10-14, a change of -57.8 % over the past year, with a market capitalization of USD 75.54M.

Cardiff Oncology, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Cardiff Oncology, Inc. key figures

Previous close

USD 0.97 (2026-10-14)

1-year change

-57.8 %

Market cap

USD 75.54M

Enterprise value

USD 41.48M

P/E ratio (trailing)

-1.67

P/E ratio (forward)

-1.82

EPS (trailing)

-0.58

EPS (forward)

-0.54

PEG ratio

n/a

Price to book

2.51

Revenue growth

-14.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

14.24

Employees

30

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Cardiff Oncology, Inc.

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with FOLFIRI and bevacizumab or FOLFOX and bevacizumab for the treatment of patients confirmed metastatic and unresectable colorectal cancer in patients with a KRAS or NRAS mutation; and TROV-054, a Phase 1b/2 single-arm clinical trial in KRAS-mutated metastatic colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Cardiff Oncology, Inc. and compare it with other stocks.